Novel Neisseria Gonorrhoeae Therapeutic Based on CMP-nonulosonate Sugars
- 詳細技術說明
- Invention encompasses a new strategy to combat drug-resistant gonorrhea. This technology manipulates the lipo-oligosacchride capping of gonococci, thereby decreasing it's fitness and virulence. By in
- *Abstract
-
Invention encompasses a new strategy to combat drug-resistant gonorrhea. This technology manipulates the lipo-oligosacchride capping of gonococci, thereby decreasing it's fitness and virulence. By interrupting the sialic acid mediated pathogenesis that contributes to drug-resistance, this intervention can render gonorrhoeae sensitive to killing by the innate immunity system.
- *IP Issue Date
- None
- *IP Type
- Other Patent
- 國家
- Not Available
- 申請號碼
- None
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
